We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$108M
(+155%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
60.42%
Top 10 Holdings %
Top 10 Hldgs %
3.93%
Holding
829
New
562
Increased
57
Reduced
34
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sprouts Farmers Market
SFM
|
+$969K |
| 2 |
TIGR
UP Fintech Holding
TIGR
|
+$737K |
| 3 |
Corporacion America
CAAP
|
+$729K |
| 4 |
LX
LexinFintech Holdings
LX
|
+$728K |
| 5 |
Wayfair
W
|
+$720K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cirrus Logic
CRUS
|
+$563K |
| 2 |
Monster Beverage
MNST
|
+$526K |
| 3 |
Clorox
CLX
|
+$510K |
| 4 |
Okta
OKTA
|
+$488K |
| 5 |
Nordson
NDSN
|
+$480K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.42% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 13.71% |
| 4 | Consumer Discretionary | 13.67% |
| 5 | Industrials | 13.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Ferrari
RACE
$66.8B
| $235K | 0.13% |
+484
| New | +$232K |
|
377
Pearson
PSO
$10.1B
| $235K | 0.13% |
+16,583
| New | +$239K |
|
378
Ionis Pharmaceuticals
IONS
$9.25B
| $235K | 0.13% |
+3,587
| New | +$175K |
|
379
St. Joe Company
JOE
$3.56B
| $235K | 0.13% |
+4,742
| New | +$239K |
|
380
Littelfuse
LFUS
$10.2B
| $234K | 0.13% |
+905
| New | +$227K |
|
381
Coca-Cola
KO
$362B
| $234K | 0.13% |
+3,525
| New | +$243K |
|
|
HSII
382
DELISTED
Heidrick & Struggles
HSII
| $233K | 0.13% |
+4,691
| New | +$226K |
|
383
US Foods
USFD
$21.9B
| $233K | 0.13% |
3,044
-1,475
| -33% | -$117K |
|
384
Alpha Teknova
TKNO
$260M
| $233K | 0.13% |
37,645
+19,149
| +104% | +$90K |
|
385
Runway Growth Finance
RWAY
$231M
| $233K | 0.13% |
22,929
+1,955
| +9% | +$21K |
|
386
Casey's General Stores
CASY
$31.6B
| $233K | 0.13% |
+412
| New | +$216K |
|
387
Ascendis Pharma A/S
ASND
$16.6B
| $233K | 0.13% |
+1,170
| New | +$218K |
|
388
Neuropace
NPCE
$522M
| $232K | 0.13% |
+22,456
| New | +$212K |
|
389
Stepan Co
SCL
$1.31B
| $231K | 0.13% |
+4,846
| New | +$251K |
|
390
WSFS Financial
WSFS
$4.14B
| $231K | 0.13% |
+4,276
| New | +$241K |
|
391
Sibanye-Stillwater
SBSW
$6.05B
| $230K | 0.13% |
+20,460
| New | +$179K |
|
|
JCAP
392
Jefferson Capital
JCAP
$1.26B
| $230K | 0.13% |
+13,321
| New | +$237K |
|
|
FINV
393
FinVolution Group
FINV
$1.15B
| $230K | 0.13% |
+31,187
| New | +$273K |
|
394
Medpace
MEDP
$16.5B
| $230K | 0.13% |
+447
| New | +$195K |
|
|
MPT
395
Medical Properties Trust
MPT
$2.86B
| $230K | 0.13% |
+45,271
| New | +$199K |
|
396
SEI Investments
SEIC
$12.2B
| $229K | 0.13% |
+2,699
| New | +$240K |
|
397
Federal Realty Investment Trust
FRT
$11B
| $229K | 0.13% |
+2,260
| New | +$218K |
|
398
Eton Pharmaceutcials
ETON
$1.16B
| $229K | 0.13% |
+10,535
| New | +$175K |
|
399
Choice Hotels
CHH
$5.15B
| $229K | 0.13% |
+2,141
| New | +$261K |
|
400
Hudbay
HBM
$9.96B
| $228K | 0.13% |
+15,069
| New | +$173K |
|
Similar funds
BS
RG
MP
AIA
CCM
DFA
CCP
FRT
PharVision Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, PharVision Advisers held 829 positions worth $178M, up 155% from $69.6M the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.
PharVision Advisers deployed $107M of net new capital in Q3 2025, opening 562 new positions and adding to 57 existing holdings. Its largest new stake was Sprouts Farmers Market: 6,658 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Western Union, an estimated $321K trimmed.
- PharVision Advisers's largest Q3 2025 buy was Sprouts Farmers Market: 6,658 shares worth $724K.
- PharVision Advisers added most to Gogo Inc in Q3 2025, an estimated $397K increase.
- PharVision Advisers's biggest Q3 2025 reduction was Western Union, cutting an estimated $321K.
- PharVision Advisers fully exited Cirrus Logic in Q3 2025, selling an estimated $563K.
- PharVision Advisers's ten largest holdings make up 3.9% of its $178M portfolio in Q3 2025.
- PharVision Advisers opened 562 new positions and closed 175 in Q3 2025.
- PharVision Advisers's portfolio value rose 155% quarter-over-quarter to $178M.
Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.